Inventor · disambiguated record
Xiaolan Zhou
Also filed as: ZHOU XIAOLAN
30 granted patents·18 pending applications·472 citations·filing 2006–2024
97Inventor score
Top patents by PatentIndex Score
48 records- 0198US8999917B2Variant activin receptor polypeptides and uses thereofAMGEN INC·Filed 2013·Granted Apr 7, 2015·48 cites·19 claims
- 0297US7947646B2Variant activin receptor polypeptidesAMGEN INC·Filed 2008·Granted May 24, 2011·66 cites·24 claims
- 0396US9809638B2Variant activin receptorAMGEN INC·Filed 2016·Granted Nov 7, 2017·25 cites·20 claims
- 0496US8716459B2Isolated nucleic acid molecules encoding variant activin receptor polypeptidesSUN JEONGHOON·Filed 2011·Granted May 6, 2014·48 cites·32 claims
- 0596US8309082B2Anti-activin A antibodies and uses thereofHAN HUI-QUAN·Filed 2007·Granted Nov 13, 2012·68 cites·8 claims
- 0695US8753627B2Anti-activin a antibodies and uses thereofHAN HUI-QUAN·Filed 2012·Granted Jun 17, 2014·37 cites·31 claims
- 0795US8501678B2Variant activin receptor polypeptides and uses thereofSUN JEONGHOON·Filed 2011·Granted Aug 6, 2013·38 cites·20 claims
- 0894US11983553B2Conversational interface for content creation and editing using large language modelsGOOGLE LLC·Filed 2022·Granted May 14, 2024·11 cites·20 claims
- 0994US8067562B2Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1HAN HQ·Filed 2006·Granted Nov 29, 2011·30 cites·11 claims
- 1093US10407487B2Variant activin receptorAMGEN INC·Filed 2017·Granted Sep 10, 2019·11 cites·20 claims
- 1191US9447165B2Variant activin IIB receptorAMGEN INC·Filed 2014·Granted Sep 20, 2016·11 cites·20 claims
- 1291US9284364B2Isolated nucleic acid molecule encoding a fusion protein comprising an activin receptorAMGEN INC·Filed 2013·Granted Mar 15, 2016·13 cites·20 claims
- 1391US8999343B2Antibodies that bind myostatin, compositions and methodsHAN HUIQUAN·Filed 2011·Granted Apr 7, 2015·28 cites·10 claims
- 1490US8614292B2Isolated protein comprising an activin type IIB5 receptor polypeptide and uses thereofHAN HQ·Filed 2011·Granted Dec 24, 2013·13 cites·16 claims
- 1587US9610327B2Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereofAMGEN INC·Filed 2012·Granted Apr 4, 2017·11 cites·19 claims
- 1687US9453080B2Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2013·Granted Sep 27, 2016·4 cites·21 claims
- 1785US2024327526A1Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 1883US8949385B2Method and apparatus for resolving conflicting unicast advertisements in a transport networkKEESARA SRIKANTH·Filed 2011·Granted Feb 3, 2015·7 cites·20 claims
- 1980US2024262883A1Novel hybrid actriib ligand trap proteins for treating muscle wasting diseasesALIVEGEN INC·Filed 2024·Application pending·0 cites
- 2078US10913782B2Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseasesBIOGEN MA INC·Filed 2016·Granted Feb 9, 2021·1 cites·28 claims
- 2178US2025109183A1Methods for treating muscle wasting and bone disease using novel hybrid actriib ligand trap proteinsALIVEGEN INC·Filed 2024·Application pending·0 cites
- 2276US12383572B2Administration of an anti-activin-a compound to a subjectAMGEN INC·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 2375US11932677B2Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseasesALIVEGEN INC·Filed 2022·Granted Mar 19, 2024·0 cites·4 claims
- 2474US12386643B2Conversational interface for content creation and editing using large language modelsGOOGLE LLC·Filed 2024·Granted Aug 12, 2025·0 cites·20 claims
- 2574US11292826B2Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseasesBIOGEN MA INC·Filed 2020·Granted Apr 5, 2022·0 cites·16 claims
- 2673US12187783B2Methods for treating muscle wasting and bone disease using novel hybrid ActRIIB ligand trap proteinsALIVEGEN INC·Filed 2021·Granted Jan 7, 2025·0 cites·8 claims
- 2773US11542325B2Anti-activin A antibodies and uses thereofAMGEN INC·Filed 2018·Granted Jan 3, 2023·0 cites·4 claims
- 2873US2021340262A1Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2021·Application pending·0 cites
- 2971US11541070B2Administration of an anti-activin-A compound to a subjectAMGEN INC·Filed 2019·Granted Jan 3, 2023·0 cites·1 claims
- 3071US10981999B2Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2019·Granted Apr 20, 2021·0 cites·7 claims
- 3167US2024394754A1Digital Content CreationGOOGLE LLC·Filed 2024·Application pending·0 cites
- 3264US9813257B2Access network dual path connectivityKEESARA SRIKANTH·Filed 2010·Granted Nov 7, 2017·2 cites·18 claims
- 3363US10266598B2Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2016·Granted Apr 23, 2019·0 cites·11 claims
- 3462US2015086556A1Anti-Activin A Antibodies and Uses ThereofAMGEN INC·Filed 2014·Application pending·0 cites
- 3561US10100109B2Anti-activin A antibodies and uses thereofAMGEN INC·Filed 2016·Granted Oct 16, 2018·0 cites·2 claims
- 3659US2019330307A1Methods for treating muscle wasting and bone disease using novel hybrid actriib ligand trap proteinsBIOGEN MA INC·Filed 2017·Application pending·0 cites
- 3759US2025356395A1Content Group Generation for Content Delivery CampaignsGOOGLE LLC·Filed 2024·Application pending·0 cites
- 3857US2023391863A1Bifunctional antagonists of activin and tumor necrosis factor alpha and uses thereofHAN HQ·Filed 2021·Application pending·0 cites
- 3957US2024343788A1Novel bifunctional multispecific antagonists capable of inhibiting multiple ligands of tgf-beta family and uses thereofHAN HQ·Filed 2021·Application pending·0 cites
- 4057US2015231206A1Variant activin receptor polypeptides and uses thereofAMGEN INC·Filed 2015·Application pending·0 cites
- 4157US2023391880A1Bifunctional antagonists of activin/tgf-beta and rankl and uses thereofHAN HQ·Filed 2021·Application pending·0 cites
- 4256US2023391892A1Bifunctional antagonists of tumor necrosis factor alpha and transforming growth factor beta and uses thereofHAN HQ·Filed 2021·Application pending·0 cites
- 4354US2016152683A1Novel activin receptor and uses thereofAMGEN INC·Filed 2016·Application pending·0 cites
- 4450US2015359850A1Administration of an anti-activin-a compound to a subjectSANTA MARIA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4550US2024126997A1Conversational Interface for Content Creation and Editing using Large Language ModelsGOOGLE LLC·Filed 2023·Application pending·0 cites
- 4648US10594512B2Access network dual path connectivityEXTREME NETWORKS INC·Filed 2017·Granted Mar 17, 2020·0 cites·20 claims
- 4741US2015322144A1Antibodies that Bind Myostatin, Compositions and MethodsAMGEN INC·Filed 2015·Application pending·0 cites
- 4840US2014220033A1Administration of an Anti-Activin-A Compound to a SubjectSANTA MARIA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaolan Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →